Pages that link to "Q30401633"
Jump to navigation
Jump to search
The following pages link to Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. (Q30401633):
Displaying 21 items.
- Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk (Q27330166) (← links)
- The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment (Q30205724) (← links)
- Exploring a proposed WHO method to determine thresholds for seasonal influenza surveillance. (Q30354787) (← links)
- Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses. (Q30371873) (← links)
- Transmission of the First Influenza A(H1N1)pdm09 Pandemic Wave in Australia Was Driven by Undetected Infections: Pandemic Response Implications. (Q30382760) (← links)
- Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach (Q30383722) (← links)
- Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses. (Q30413786) (← links)
- No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009. (Q30415608) (← links)
- Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls (Q30417417) (← links)
- Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization (Q30419179) (← links)
- Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan (Q30421614) (← links)
- Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population (Q30429711) (← links)
- Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers (Q30431452) (← links)
- Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1. (Q30432591) (← links)
- Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review (Q34778408) (← links)
- Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine (Q36115609) (← links)
- Viva la revolución: rethinking influenza a virus antigenic drift (Q37950365) (← links)
- Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review (Q38819920) (← links)
- Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. (Q44243917) (← links)
- Variable definitions of the influenza season and their impact on vaccine effectiveness estimates (Q45760952) (← links)
- The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology (Q90692852) (← links)